Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.

As the Trump administration moves to limit COVID booster vaccines for some, here's what to know about the latest variant NB.1 ...

New tools, treatment options, and precision medicine developments are leading to better quality of life and survival for ...

FDA approves Nucala as add-on therapy for COPD with high eosinophils, offering new hope by reducing flare-ups in patients ...

The FDA has granted approval to GSK's Nucala as an add-on maintenance treatment for adult patients suffering from inadequately controlled COPD.

The COPD approval marks the fifth Nucala has received from the FDA, following green lights in severe asthma, chronic ...

A BMJ Open Respiratory Research study finds women aged over 40 face a 50% higher risk of developing COPD than men—even ...

Learn the warning signs that differentiate harmless coughs from those requiring medical attention, including timeline ...

University of Alabama at Birmingham-led researchers have refined and validated a new framework for diagnosing chronic ...

Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the male ...

Current recommendations for diagnosis of COPD in patients with respiratory symptoms require detection of airflow obstruction ...

Including imaging and symptom-based data in COPD diagnosis captures patients with high-risk disease otherwise overlooked.